Research programme: sigma 1 receptor antagonists - NeurotechAlternative Names: NP-07; NP-2007
Latest Information Update: 28 Aug 2012
At a glance
- Originator Neurotech Pharmaceuticals
- Developer GNT Pharma
- Mechanism of Action Glutamate agonists; Sigma-1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Neuropathic pain; Pain
Most Recent Events
- 28 Aug 2012 No development reported - Preclinical for Pain in South Korea (unspecified route)
- 28 Aug 2012 No development reported - Preclinical for Neuropathic pain in South Korea (unspecified route)
- 22 Aug 2007 Preclinical trials in Pain in South Korea (unspecified route)